NCT04416568
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04416568
Title Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Benioff Children's Hospital San Francisco California 94158 United States Details
Children's Healthcare of Atlanta-Egleston Atlanta Georgia 30322 United States Details
Children's Healthcare of Atlanta-Scottish Rite Atlanta Georgia 30342 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Boston Children's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field